PainCart Study Evaluating the Analgesic Profile of SAGE-319

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2025-521380-12-00

Acronym

319-TRM-101

Enrollment

Registered

2025-05-30

Start date

2025-06-02

Completion date

2025-06-17

Last updated

2025-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders characterized by a deficit in GABAergic signaling and cerebellar circuitry.

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026